CSN welcomes Erica Song, MD, FACOG from Englewood, New Jersey and orthopedic surgeon Marc A. Roux, MD, FAAOS from Waxahachie, Texas. Erica Song, MD, FACOG Founder, New Jersey Stem Cell Treatment Center, a division of Vibrant Life Medicine Englewood, New Jersey 201.569.6190 email@example.com http://www.vibrantlifemedicine.com Marc A. Roux, MD, FAAOS Waxahachie Orthopedics and Sports Medicine (WOSM)…Details
JUNE 5-6 2015 Dr. Berman accepted a position on the Advisory Committee for the Academy of Regenerative Practices (ARP), and presented the following lecture at their first annual conference in Fort Lauderdale, Florida. Mark Berman, MD, FACS presents: “Controlled Studies” A discussion of in-clinic cellular treatments and current empirical findings. Results are largely positive, and dependent upon…Details
Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. The study involved 21 people whose disability due to MS had…Details
Evidence-based medicine and intuition both work By Devorah E. Klein, Gary Klein, and Shawna J. Perry | June 11, 2014, Wednesday | Print Edition EVERY health-care system balances coverage, quality and cost — often focusing on one or two at the expense of the others. It is clear that the US has room for improvement…Details
Board Certified Ophthalmologist Dr. David Milstein and CSN co-founder Dr. Elliot Lander. Cell Surgical Network performed their first Stromal Vascular Fraction (SVF) retrobulbar deployment for Leber’s optic neuropathy in our Rancho Mirage office. The patient is doing well and we are excited to see the long term benefits of CSN’s new Institutional Review Board (IRB) approved…Details
CSN was pleased to be included in this About.com article by internationally renowned thyroid patient advocate and author Mary Shomon.
BONE MARROW VS. FAT DERIVED STEM CELLS- IS THERE A CONTROVERSY? Whether your adult mesenchymal stem cells come from bone marrow or from fat probably does not make a difference in terms of clinical results. Although some centers claim that bone marrow derived cells are superior to fat derived cells, there is no evidence to…Details